MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2147/ndt.s116476

Медицинская библиотека · Neuropsychiatric disease and treatment · 2016

Rasagiline for sleep disorders in patients with Parkinson's disease: a prospective observational study.

Schettino Carla, Dato Clemente, Capaldo Guglielmo, Sampaolo Simone, Di Iorio Giuseppe, Melone Mariarosa Ab

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Rasagiline is a selective, irreversible monoamine oxidase B inhibitor that ameliorates the symptoms of Parkinson's disease (PD) by inhibiting striatal dopamine metabolism. There is also evidence that monoamine oxidase B inhibitors increase melatonin levels in the pineal gland and may have a beneficial effect on sleep disorders, which are a common feature in patients with PD.

METHODS

This single-center, prospective, observational, 12-week study compared the effect of combination therapy with levodopa 200-300 mg/d + rasagiline 1 mg/d (n=19) with levodopa 200-300 mg/d alone (n=19) in the treatment of sleep disorders in patients with idiopathic PD.

RESULTS

After 12 weeks' treatment, mean sleep latency was significantly (P<0.001) lower and the improvement in sleep latency from baseline was significantly (P=0.001) greater in patients receiving levodopa + rasagiline than in patients receiving levodopa alone. Similarly, at the end of the study, the mean total sleep time was significantly (P=0.002) longer and the improvement from baseline in mean total sleep time was significantly (P=0.026) greater in patients receiving levodopa + rasagiline than levodopa alone. There were no significant differences between treatment groups for the mean number of awakenings reported at week 12 nor the change from baseline to week 12 in mean number of awakenings.

CONCLUSION

Adding rasagiline to levodopa improved sleep outcomes and may be an appropriate option for patients with PD experiencing sleep disorders.

Для цитирования: Schettino Carla, Dato Clemente, Capaldo Guglielmo, Sampaolo Simone, Di Iorio Giuseppe, Melone Mariarosa Ab. Rasagiline for sleep disorders in patients with Parkinson's disease: a prospective observational study.. Neuropsychiatric disease and treatment. 2016. DOI: 10.2147/ndt.s116476.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.